감염 감시 솔루션 시장 : 제품 및 서비스별, 감염 유형별, 최종 사용자별, 지역별
Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User and By Geography
상품코드
:
1747574
리서치사
:
Coherent Market Insights
발행일
:
2025년 05월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
감염 감시 솔루션 시장은 2025년에는 8억 9,200만 달러로 추정되고, 2032년에는 22억 5,960만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 CAGR은 14.2%를 나타낼 것으로 전망됩니다.
| 분석 범위 |
분석 상세 |
| 기준 연도 |
2024년 |
시장 규모(2025년) |
8억 9,200만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측기간 CAGR(2025-2032년) |
14.20% |
예측 금액(2032년) |
22억 5,960만 달러 |
감염 감시 솔루션은 병원과 같은 의료 시설이 환자와 관련된 데이터를 주 및 연방 당국에 보고하는 데 도움이 되는 소프트웨어입니다. 병원이나 의료 센터에서 사람들에게 퍼지는 감염입니다. 원료를 피하기 위해 감염으로 고통받는 환자를 치료할 수 있습니다. 의료 관련 감염(HAI)의 높은 발생률은 세계의 정부의 주요 관심사이며, 이에 따라 여러 정부에서 HAI를 효과적으로 관리하고 발생을 줄이기 위한 정책을 마련하고 있습니다.
시장 역학
제품 포트폴리오를 확대하기 위해 시장 주요 기업이 인수와 같은 무기 성장 전략을 채택하는 것이 증가하고 있으며 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 예를 들어, 2019년 5월 소프트웨어 회사인 RLDatix는 여러 산업 분야에 클라우드 기반 계약, 규정 준수 및 수익 관리 소프트웨어를 제공하는 iContracts를 인수했다고 발표했습니다. 이 인수를 통해 RLDatix의 환자 안전 플랫폼과 iContracts의 첨단 정책 관리 기능이 통합되어 조직은 처음으로 동적 정책과 절차의 도입을 통해 인시던트의 근본 원인에 대책을 강구할 수 있게 됩니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 감염 감시 솔루션 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모·CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝혀 이 시장의 매력적인 투자 제안의 매트릭스에 대해 설명하고 있습니다.
- 또, 시장 성장 촉진요인 및 억제요인이나 기회, 신제품의 출시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 세계의 감염 감시 솔루션 시장에 있어서 주요 기업 프로파일을, 기업 개요, 제품 포트폴리오, 주요한 하이라이트, 재무 실적, 전략 등의 이하의 파라미터에 근거해 제공합니다.
- 본 보고서의 인사이트를 이용해, 마케팅 담당자나 기업의 경영진이, 향후 제품 발매·제휴·시장 확대·마케팅 전술에 관한, 충분한 정보에 근거한 의사 결정을 내릴 수 있습니다.
- '세계의 감염 감시 솔루션 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자에 대응하고 있습니다.
- 이해관계자는 세계의 감염 감시 솔루션 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학·규제·동향의 분석
- 시장 역학
- 영향 분석
- 주요 하이라이트
- 제품 발매
- 기술진보
- PEST 분석
- 규제 시나리오
- 기업 합병·인수(M&A)
제4장 세계의 감염 감시 솔루션 시장 : 제품 및 서비스별(2020-2032년)
제5장 세계의 감염 감시 솔루션 시장 : 감염 유형별(2020-2032년)
제6장 세계의 감염 감시 솔루션 시장 : 최종 사용자별(2020-2032년)
- 병원
- 클리닉
- 외래수술센터(ASC)
- 기타(전문센터 등)
제7장 세계의 감염 감시 솔루션 시장 : 지역별(2020-2032년)
- 북미
- 라틴아메리카
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 중동
- 아프리카
제8장 경쟁 구도
- Baxter
- BD
- STERIS
- Getinge AB
- Medtronic
- Koninklijke Philips NV
- Abbott
- Medexter Healthcare
- Asolva
- GOJO Industries, Inc.
- Wolters Kluwer NV
- VigiLanz Corporation
- RLDatix
- Roper Technologies, Inc.
- Health Outcomes Worldwide
- OpGen, Inc.
- Urovant Sciences
- Premier
제9장 섹션
KTH
영문 목차
Infection Surveillance Solutions Market is estimated to be valued at USD 892 Mn in 2025 and is expected to reach USD 2,259.6 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 14.2% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 892 Mn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
14.20% |
2032 Value Projection: |
USD 2,259.6 Mn |
Infection surveillance solution is software that helps healthcare facilities such as hospitals and others to report data related to patients, to the state and federal authorities. Infection surveillance solutions are used in the healthcare industry to collect data on nosocomial infections to study the pattern of infections and regulate their spread in the community. Nosocomial infections are infections that are spread to people from hospitals or healthcare centers. This software alerts hospital Internet Protocol (IPs) in case of infection occurrence so that HAI specialists and nurses can treat patients suffering from the infection in order to avoid outbreaks of infection. Infection surveillance solutions are programs, which help in the effective management of the Healthcare-Acquired Infections (HAIs) in healthcare facilities. Pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and infections related to some surgery are the few major Healthcare-Acquired Infections (HAIs). High incidences of Healthcare-Acquired Infections (HAIs) is a major concern for government across the globe, and hence, various governments have outlined policies to effectively manage and reduce incidences of HAIs.
Market Dynamics
Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in May 2019, RLDatix, a software company, announced that they had acquired iContracts, a provider of cloud-based contract, compliance, and revenue management software for multiple industries. The acquisition brings together the RLDatix patient safety platform with iContracts leading policy management capabilities to allow organizations, for the first time, to take action on the root causes of incidents through the implementation of policies and procedures that are dynamic.
Key features of the study
- This report provides in-depth analysis of the global infection surveillance solutions market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global infection surveillance solutions market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study are Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences, and Premier
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global infection surveillance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infection surveillance solutions market
Market Segmentation
- Global Infection Surveillance Solutions Market, By Products and Services
- Software
- On-Premises
- Web-Based
- Services
- Support & Maintenance
- Training & Consulting
- Global Infection Surveillance Solutions Market, By Infection Type
- Surgical Site Infections
- Blood Stream Infections
- Urinary Tract Infections
- Global Infection Surveillance Solutions Market, By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Other (Specialty Center, etc.)
- Global Infection Surveillance Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Baxter
- BD
- STERIS
- Getinge AB
- Medtronic
- Koninklijke Philips N.V.
- Abbott
- Medexter Healthcare
- Asolva
- GOJO Industries, Inc.
- Wolters Kluwer N.V.
- VigiLanz Corporation
- RLDatix
- Roper Technologies, Inc.
- Health Outcomes Worldwide
- OpGen, Inc.
- Urovant Sciences
- Premier
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Products and Services
- Market Snapshot, By Infection Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product Launch
- Technological Advancements
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
4. Global Infection Surveillance Solutions Market, By 2020 - 2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Support & Maintenance
- Training & Consulting
5. Global Infection Surveillance Solutions Market, By Infection Type, 2020 - 2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Surgical Site Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Blood Stream Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
6. Global Infection Surveillance Solutions Market, By End User, 2020 - 2032, (US$ Million)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Ambulatory Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
- Others (Specialty Center, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
7. Global Infection Surveillance Solutions Market, By Region, 2020 - 2032, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Baxter
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- STERIS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medexter Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Asolva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GOJO Industries, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Wolters Kluwer N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- VigiLanz Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- RLDatix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Roper Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Health Outcomes Worldwide
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OpGen, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Urovant Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Premier
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
관련자료
